How to cope with the “big killers” in Spain | Business | EUROtoday

Known within the medical subject because the “big killers”, cardiovascular illnesses and most cancers are the primary causes of mortality within the nation, representing an infinite problem for the well being system. These pathologies not solely have an effect on the well being of the inhabitants, but in addition generate a powerful financial and social impression, rising medical prices, rising sick go away and inflicting psychological results on sufferers and their households.

Prevention is important to cut back its incidence, and on this sense, the pharmaceutical business performs a vital function by growing revolutionary therapies and collaborating with the general public sector to enhance the standard of lifetime of sufferers. To delve into the challenges of going through these illnesses, EL PAÍS and Novartis have convened a sequence of specialists to debate the subject.

The assembly — which will probably be held this coming Monday, October 21, beginning at 11 a.m. and which will be adopted stay by this newspaper’s web site, in addition to on its social networks — will probably be attended by César Hernández García, director General Common Portfolio of Services of the National Health System (SNS).

During the occasion, which will probably be moderated by Carlos de Vega, deputy director of Information at Prisa Vídeo, a spherical desk will probably be held wherein Dr. Javier de Castro, scientific director of the La Paz University Hospital Research Institute (IdiPAZ) will take part. ; Dr. Miguel Martín, president of the Spanish Breast Cancer Research Group Foundation (Geicam); Carina Escobar, president of the Patients Platform (POP); Dr. Luis Rodríguez Padial, president of the Spanish Society of Cardiology (SEC); Dr. César Rodríguez, president of the Spanish Society of Medical Oncology (SEOM), and Jesús Ponce, president of Novartis Spain.